Exponential Growth in Renal Denervation Market

  • Rising prevalence of serious health conditions is expected to drive market growth.
  • Stringent regulatory norms for renal denervation devices are expected to hamper market growth.
  • North America is dominating the global market regionally.

The global renal denervation market is estimated to value at nearly $240 million in 2019, and is expected to register a CAGR of 15.2%. The Global Renal Denervation market is segmented on the basis of technology, product type, indication, end user, and region.

Introduction

Renal denervation is a type of minimally invasive procedure which involves endovascular access from femoral artery using a catheter-mounted device into the renal artery. The device uses radiofrequency ablation, pharmacologic ablation or ultrasound ablation for the treatment of resistant high blood pressure which is unable to control by medication.

Request for sample copy of Renal Denervation Market report:

Increasing geriatric population across the globe has prompted the development of advanced renal denervation products to treat blood pressure, heart failure, diabetes, and renal failure more efficiently and improve quality of life.

Dynamics

Rising prevalence of serious health conditions such as high blood pressure or hypertension is major factors expected to drive growth of the global renal denervation market. Technological advancements to develop alternative technologies such as micro-infusion for renal denervation systems is expected to fuel growth of the global renal denervation market. Furthermore, increasing investments for innovations and research and development activities related to renal sympathetic denervation is expected to create a lucrative opportunity for growth of the global renal denervation market over the forecast period.

However, stringent regulatory norms for renal denervation devices, product recalls, and low reimbursements rates in developing countries are expected to hamper growth of the renal denervation market to a certain extent over the forecast period.

Increasing incidence of hypertension across the globe is a key factor expected to drive revenue growth of the global renal denervation market.

  • According to the Centers for Disease Control and Prevention in 2018, around one of three adults in the US – or around 75 million individuals – had high blood pressure.
  • In January 2018, the American Heart Association estimated that nearly 103 million US adults suffering from high blood pressure.

Increasing geriatric population across the globe has prompted the development of advanced renal denervation products to treat blood pressure, heart failure, diabetes, and renal failure more efficiently and improve quality of life.

  • According to the World Population Prospects 2017 report published by the United Nations, the number of persons aged 80 years and over is projected to triple from 137 Million in 2017 to 425 Million by 2050. By 2100 in addition, this number is expected to increase to 909 Million, which is around seven times that of 2017.
  • According to the United Nations, there were approximately 962 million people aged 60 years and above globally in 2017, comprising 13% of the global population. This number is projected to increase to 1.4 billion by 2030, and 2.1 billion by 2050.

Increasing number of clinical trials are ongoing and some new techniques being worked on, owing to higher demand for novel therapeutic treatment and medical devices, coupled with rising investment in research and development activities.

[cpm10]

  • In June 2019, National Institutes of Health (NIH), which is a US-based medical research center, announced a study of clinical Trial: A Phase 3, Multicenter, Blinded, Sham-Procedure Controlled Trial of Renal Denervation by the Peregrine System Kit, in Subjects with Hypertension, and is expected to complete by 2023.

Customize Report And Inquiry For The Renal Denervation Market Report:

Renal denervation is a type of minimally invasive procedure which involves endovascular access from femoral artery using a catheter-mounted device into the renal artery.

Global Renal Denervation Market Analysis, by Technology

Among the technology segments, the radiofrequency ablation segment is expected to account for major revenue share and is expected to maintain its dominance over the forecast period. The radiofrequency ablation segment is expected to register CAGR of over 15.8%.

The ultrasound ablation segment accounts for second highest share in terms of revenue in the near future. The ultrasound ablation segment is expected to register second highest CAGR of over 14.6%.

Global Renal Denervation Market Analysis, by Product Type

Among the product type segments, the catheters segment is expected to account for major revenue share and is expected to maintain its dominance over the forecast period. The catheters segment is expected to register CAGR of over 15.6%. The RF generator segment accounts for second highest share in terms of revenue in the near future. The RF generator segment is expected to register second highest CAGR of over 13.4%.

Global Renal Denervation Market Analysis, by Indication

Among the indication segments, the hypertension segment is accounted for the major revenue share and is expected to maintain its dominance over the forecast period. The hypertension segment is expected to register CAGR of over 15.3%.

Global Renal Denervation Market Analysis, by End User

Among the end user segments, the hospital segment is expected to account for major revenue share and is expected to maintain its dominance over the forecast period. The hospital segment is expected to register CAGR of over 15.9%. The heart failure segment accounts for second highest share in terms of revenue in the near future. The heart failure segment is expected to register second highest CAGR of over 13.6%.

Global Renal Denervation Market Analysis, by Region

Currently, the market in North America is dominating the global market in terms of revenue and is expected to maintain its dominance over the forecast period. Increasing research and development activities for the development of efficient devices in the countries in this region is a major factor expected to drive revenue growth of the North America renal denervation market over the next 10 years.

The Europe renal denervation market also registered significant growth in the global renal denervation market in the near future. The renal denervation market in the Asia Pacific is expected to grow at a moderate rate in terms of revenue over the forecast period. Increasing prevalence of lifestyle-related disorders such as diabetes and obesity in the countries in this region is expected to drive the growth of the market in the Asia Pacific. In addition, the increasing number of drug-resistant hypertension cases is expected to support revenue growth of renal denervation market in the Asia Pacific.

Only $1/click

Submit Your Ad Here

Leave a Reply